Mentice Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
111
- Stock Symbol
-
MNTC
- Investments
-
5
- Share Price
-
$1.63
- (As of Tuesday Closing)
Mentice General Information
Description
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
Contact Information
Website
www.mentice.comCorporate Office
- Odinsgatan 10
- 411 03 Gothenburg
- Sweden
Corporate Office
- Odinsgatan 10
- 411 03 Gothenburg
- Sweden
Mentice Timeline
Mentice Stock Performance
As of 17-Nov-2026, Mentice’s stock price is $1.63. Its current market cap is $45.9M with 28.1M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.63 | $1.68 | $1.25 - $1.99 | $45.9M | 28.1M | 11.7K | -$0.07 |
Mentice Financials Summary
As of 30-Sep-2026, Mentice has a trailing 12-month revenue of $32.5M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 37,452 | 38,363 | 55,430 | 115,707 |
| Revenue | 32,478 | 28,407 | 27,452 | 25,742 |
| EBITDA | 1,527 | 148 | 1,232 | 2,643 |
| Net Income | (1,979) | (3,291) | (1,742) | (265) |
| Total Assets | 30,266 | 33,908 | 29,356 | 32,272 |
| Total Debt | 1,407 | 1,828 | 828 | 956 |
Mentice Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Mentice Comparisons
Industry
Financing
Details
Mentice Competitors (3)
One of Mentice’s 3 competitors is Gaumard, a Corporation company based in Miami, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gaumard | Corporation | Miami, FL | ||||
| Angiodynamics | Corporation | Latham, NY | ||||
| Biotronik | Corporate Backed or Acquired | Berlin, Germany |
Mentice Patents
Mentice Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4381412-A1 | Devices, systems, and methods for 3d printing of vasculature | Pending | 02-Aug-2021 | ||
| EP-4377942-A1 | System for advanced physician training and patient specific rehearsals | Pending | 25-Jul-2021 | ||
| EP-4330990-A1 | Decision support tool for endovascular procedures | Pending | 26-Apr-2021 | ||
| US-20220338929-A1 | Decision support tool for endovascular procedures | Pending | 26-Apr-2021 | ||
| WO-2022229066-A1 | Decision support tool for endovascular procedures | Inactive | 26-Apr-2021 | G16H20/40 |
Mentice Signals
Mentice Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Mentice Acquisitions (5)
Mentice’s most recent deal was a Merger/Acquisition with Biomodex for . The deal was made on 11-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biomodex | 11-Dec-2023 | Merger/Acquisition | Other Devices and Supplies | ||
| Ankyras | 30-Jun-2022 | Merger/Acquisition | Application Software | ||
| EQIP (Medical Records Systems) | 08-Oct-2020 | Merger/Acquisition | Medical Records Systems | ||
| Vascular Simulations | 01-Oct-2020 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Medical Simulation Corporation (Medical Products Division) | 20-Dec-2017 | Merger/Acquisition | Other Devices and Supplies |
Mentice ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Mentice Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Biomodex | Paris, France | 2015 |
Mentice FAQs
-
When was Mentice founded?
Mentice was founded in 1998.
-
Where is Mentice headquartered?
Mentice is headquartered in Gothenburg, Sweden.
-
What is the size of Mentice?
Mentice has 111 total employees.
-
What industry is Mentice in?
Mentice’s primary industry is Monitoring Equipment.
-
Is Mentice a private or public company?
Mentice is a Public company.
-
What is Mentice’s stock symbol?
The ticker symbol for Mentice is MNTC.
-
What is the current stock price of Mentice?
As of 17-Nov-2026 the stock price of Mentice is $1.63.
-
What is the current market cap of Mentice?
The current market capitalization of Mentice is $45.9M.
-
What is Mentice’s current revenue?
The trailing twelve month revenue for Mentice is $32.5M.
-
Who are Mentice’s competitors?
Gaumard, Angiodynamics, and Biotronik are competitors of Mentice.
-
What is Mentice’s annual earnings per share (EPS)?
Mentice’s EPS for 12 months was -$0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process